Mai A. Bailey

711 total citations
19 papers, 541 citations indexed

About

Mai A. Bailey is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Mai A. Bailey has authored 19 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 11 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Mai A. Bailey's work include Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (10 papers) and Cancer therapeutics and mechanisms (6 papers). Mai A. Bailey is often cited by papers focused on Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (10 papers) and Cancer therapeutics and mechanisms (6 papers). Mai A. Bailey collaborates with scholars based in United States, India and Sweden. Mai A. Bailey's co-authors include Tanya Parish, Juliane Ollinger, Torey Alling, Marvin J. Miller, Garrett C. Moraski, Allen Casey, Philip A. Hipskind, Stephanie K. Florio, Jeffrey W. Cramer and Julie V. Early and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Mai A. Bailey

19 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mai A. Bailey United States 13 289 264 258 149 45 19 541
Torey Alling United States 13 289 1.0× 265 1.0× 257 1.0× 156 1.0× 49 1.1× 18 550
Julie V. Early United States 14 289 1.0× 210 0.8× 173 0.7× 217 1.5× 50 1.1× 27 534
Jan Madacki France 11 288 1.0× 210 0.8× 165 0.6× 186 1.2× 41 0.9× 14 486
O. B. Ryabova Russia 8 329 1.1× 329 1.2× 148 0.6× 149 1.0× 57 1.3× 17 537
Edward Kazyanskaya United States 6 323 1.1× 283 1.1× 120 0.5× 176 1.2× 43 1.0× 7 468
Suresh B. Lakshminarayana Singapore 12 333 1.2× 196 0.7× 110 0.4× 216 1.4× 40 0.9× 15 573
Zuzana Svetlíková Slovakia 8 219 0.8× 316 1.2× 116 0.4× 136 0.9× 31 0.7× 9 464
Michael Goodwin United States 10 366 1.3× 290 1.1× 153 0.6× 210 1.4× 56 1.2× 14 579
Stanislav Huszár Slovakia 10 256 0.9× 298 1.1× 169 0.7× 115 0.8× 20 0.4× 12 451
Kenia Pissinate Brazil 11 148 0.5× 158 0.6× 174 0.7× 74 0.5× 24 0.5× 24 362

Countries citing papers authored by Mai A. Bailey

Since Specialization
Citations

This map shows the geographic impact of Mai A. Bailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mai A. Bailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mai A. Bailey more than expected).

Fields of papers citing papers by Mai A. Bailey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mai A. Bailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mai A. Bailey. The network helps show where Mai A. Bailey may publish in the future.

Co-authorship network of co-authors of Mai A. Bailey

This figure shows the co-authorship network connecting the top 25 collaborators of Mai A. Bailey. A scholar is included among the top collaborators of Mai A. Bailey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mai A. Bailey. Mai A. Bailey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kumar, Anuradha, Somsundaram Chettiar, Brian S. Brown, et al.. (2022). Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screening. Scientific Reports. 12(1). 14879–14879. 5 indexed citations
2.
Ollinger, Juliane, Anuradha Kumar, David M. Roberts, et al.. (2019). A high-throughput whole cell screen to identify inhibitors of Mycobacterium tuberculosis. PLoS ONE. 14(1). e0205479–e0205479. 18 indexed citations
3.
Odingo, Joshua, Julie V. Early, Mai A. Bailey, et al.. (2019). 8‐Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis. Drug Development Research. 80(5). 566–572. 18 indexed citations
4.
Singh, Sheo B., Joshua Odingo, Mai A. Bailey, et al.. (2018). Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosis. BMC Research Notes. 11(1). 416–416. 2 indexed citations
5.
Files, Megan, Mai A. Bailey, Torey Alling, et al.. (2018). Construction of an overexpression library for Mycobacterium tuberculosis. Biology Methods and Protocols. 3(1). bpy009–bpy009. 9 indexed citations
6.
Bailey, Mai A., Hana Na, Malcolm S. Duthie, et al.. (2017). Nitazoxanide is active against Mycobacterium leprae. PLoS ONE. 12(8). e0184107–e0184107. 13 indexed citations
7.
Odingo, Joshua, Mai A. Bailey, Megan Files, et al.. (2017). In Vitro Evaluation of Novel Nitazoxanide Derivatives against Mycobacterium tuberculosis. ACS Omega. 2(9). 5873–5890. 20 indexed citations
8.
Kesicki, Edward A., Mai A. Bailey, Yulia Ovechkina, et al.. (2016). Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents. PLoS ONE. 11(5). e0155209–e0155209. 50 indexed citations
9.
Early, Julie V., Allen Casey, A. MARTINEZ‐GRAU, et al.. (2016). Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 60(6). 3608–3616. 25 indexed citations
10.
Alling, Torey, Mai A. Bailey, Aaron Korkegian, et al.. (2015). The 4-aminopiperidine series has limited anti-tubercular and anti-staphylococcus aureus activity. Journal of Negative Results in BioMedicine. 14(1). 4–4. 1 indexed citations
11.
Russo, Francesco, Johan Gising, A.K. Roos, et al.. (2015). Optimization and Evaluation of 5‐Styryl‐Oxathiazol‐2‐one Mycobacterium tuberculosis Proteasome Inhibitors as Potential Antitubercular Agents. ChemistryOpen. 4(3). 342–362. 10 indexed citations
12.
Alling, Torey, Mai A. Bailey, Megan Files, et al.. (2015). Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity. Journal of Medicinal Chemistry. 58(18). 7273–7285. 34 indexed citations
13.
Odingo, Joshua, Theresa O’Malley, Edward A. Kesicki, et al.. (2014). Synthesis and evaluation of the 2,4-diaminoquinazoline series as anti-tubercular agents. Bioorganic & Medicinal Chemistry. 22(24). 6965–6979. 26 indexed citations
14.
O’Malley, Theresa, Edward A. Kesicki, Torey Alling, et al.. (2014). Bioorganic & Medicinal Chemistry 22 (2014) 6965–6979. 24 indexed citations
15.
Moraski, Garrett C., Patricia A. Miller, Mai A. Bailey, et al.. (2014). Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and “Anagrams” Generated Potent Antituberculosis Agents. ACS Infectious Diseases. 1(2). 85–90. 43 indexed citations
16.
Bailey, Mai A., Megan Files, Torey Alling, et al.. (2014). Synthesis and anti-tubercular activity of 3-substituted benzo[b]thiophene-1,1-dioxides. PeerJ. 2. e612–e612. 15 indexed citations
17.
Kumar, Deepak, Mai A. Bailey, Tanya Parish, & Diwan S. Rawat. (2014). Synthesis and antituberculosis activity evaluation of cyclohexane-1,2-diamine derivatives. 2 indexed citations
18.
Ollinger, Juliane, Mai A. Bailey, Garrett C. Moraski, et al.. (2013). A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis. PLoS ONE. 8(4). e60531–e60531. 138 indexed citations
19.
Moraski, Garrett C., Lowell D. Markley, Jeffrey W. Cramer, et al.. (2013). Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and nM Activity vs. Mycobacterium tuberculosis. ACS Medicinal Chemistry Letters. 4(7). 675–679. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Torey Alling Breakdown of academic impact, for papers by Julie V. Early Breakdown of academic impact, for papers by Jan Madacki Breakdown of academic impact, for papers by O. B. Ryabova Breakdown of academic impact, for papers by Edward Kazyanskaya Breakdown of academic impact, for papers by Suresh B. Lakshminarayana Breakdown of academic impact, for papers by Zuzana Svetlíková Breakdown of academic impact, for papers by Michael Goodwin Breakdown of academic impact, for papers by Stanislav Huszár Breakdown of academic impact, for papers by Kenia Pissinate
Rankless by CCL
2026